OBJECTIVES: Assessment of the adjustable continence therapy device (ACT) in the treatment of female stress or mixed urinary incontinence in terms of efficacy and complications.
MATERIAL: Between April 2005 and September 2011, the device ACT was put by two different operators to treat a stress and/or mixed urinary incontinence at women. The results were studied under two shutters: complications and efficacy.
RESULTS: Seventy-seven women were operated. Mean age of the patients was of 68 years (34-87). Mean follow-up was of 22 months (1-72). Over the 77 patients, eight peroperative complications (10%) were noted. Twenty-five explantations were required in 22 patients (28%). In terms of efficacy, after an average follow-up of 22 months, the results were: 19 patients (25%) were continents, 25 (33%) very improved and five (6%) improved regards to the initial stage preceding the implantation. Fifteen patients (19%) were in failure. Seven patients (9%) were unchanged and in the course of adjustment (recent implantation) and six others (8%) explanted waiting for another implantation.
CONCLUSION: The ACT procedure was feasible on a population of multi-operated women with 64% of improvement in our hands. Complications were rare, easily detected and repaired. The risk of explantation was reported to be 28%.
Written by:
Nacir M, Ballanger P, Donon L, Bernhard JC, Douard A, Marit-Ducamp E, Ferriere JM, Pasticier G. Are you the author?
Service d'urologie, andrologie et transplantation rénale, groupe hospitalier Pellegrin, CHU Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France.
Reference: Prog Urol. 2013 Apr;23(4):276-82.
doi: 10.1016/j.purol.2013.02.002
PubMed Abstract
PMID: 23544986
Article in French.
UroToday.com Stress Urinary Incontinence Section
